Aptus Pharma Ltd. Announces Increase in Authorized Share Capital and Bonus Equity Share Issue
Aptus Pharma Ltd. announced on March 26, 2026, that its Board of Directors approved an increase in the company’s Authorized Share Capital and a bonus equity share issue in a ratio of 3:2.The bonus equity share issue will involve the capitalization of ₹10,29,00,000 from the company's Securities Premium Account, resulting in the issuance of 1,02,90,000 equity shares with a face value of ₹10 each. This translates to a total issuance value of ₹10,29,00,000.Share Capital details are presented in the table below:ParticularsPre Bonus IssuePost Bonus IssueShare CapitalNo. of Shares68,60,0001,02,90,000Face Value (in Rs.)1010...